3 years ago

CCR2+ monocytic-Myeloid Derived Immunosuppressive Cells (M-MDSC) inhibit collagen degradation and promote lung fibrosis by producing TGF-β1

Dominique Lison, Francine Uwambayinema, Xavier Izquierdo Carerra, Doriana Ricci, Sandra Lo Re, François Huaux, Yousof Yakoub, Mathilde Chantry, Manolis Pasparakis, Lisa Brombin, Raynal Devosse, Astrid Lebrun, Mihaly Palmai-Pallag, Saloua Ibouraadaten
Monocytes infiltrating scar tissue are predominantly viewed as progenitor cells. Here, we show that tissue CCR2+ monocytes possess specific immunosuppressive and pro-fibrotic functions. CCR2+ monocytic cells are acutely recruited to the lung before the onset of silica-induced fibrosis in mice. These tissue monocytes are defined as monocytic-Myeloid-Derived Suppressor Cells (M-MDSC) because they significantly suppress T lymphocyte proliferation in vitro. M-MDSC collected from silica-treated mice also express TGF-β1, which stimulates lung fibroblasts to release TIMP-1, an inhibitor of metalloproteinase collagenolytic activity. By using LysMCreCCR2loxP/loxP mice, we show that limiting CCR2+ M-MDSC accumulation reduces pulmonary content of TGF-β1, TIMP-1 and collagen after silica treatment. M-MDSC do not differentiate into lung macrophages, granulocytes or fibrocytes during pulmonary fibrogenesis. Collectively, our data indicate that M-MDSC contribute to lung fibrosis by specifically promoting a non-degrading collagen microenvironment.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/path.4956

You might also like
Never Miss Important Research

Researcher is an app designed by academics, for academics. Create a personalised feed in two minutes.
Choose from over 15,000 academics journals covering ten research areas then let Researcher deliver you papers tailored to your interests each day.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.